Search Results

Drugs to Watch: Agents with New Mechanisms.

Subjects: DRUG therapy for schizophrenia; THERAPEUTIC use of monoclonal antibodies; HEPARIN antagonistsUNITED States. Food & Drug Administration

• Source: Formulary Watch. Apr2024, p6-9. 4p.

Record details

FDA Issues Complete Response Letter for Cosibelimab in Cutaneous Squamous Cell Carcinoma.

Subjects: *MANUFACTURING industries; *DRUG packaging; *DRUG labelingUNITED States. Food & Drug Administration

• Source: Formulary Watch. 12/18/2023, p1-2. 2p.

Record details

FDA Approves Veopoz for Hereditary Immune Disease.

Subjects: GENETICS of autoimmune diseases; THERAPEUTIC use of monoclonal antibodies; DRUG approvalUNITED States. Food & Drug Administration

• Source: Formulary Watch. 8/21/2023, p1-2. 2p.

Record details

FDA Approves Jemperli as Frontline Treatment for Advanced Endometrial Cancer.

Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG approval; DISEASE progressionUNITED StatesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 8/1/2023, p1-2. 2p.

Record details

Treating complex cases of nAMD and DME.

• Authors : Charters, Lynda

Subjects: *RETINAL disease diagnosis; *THERAPEUTIC use of monoclonal antibodies; *EYE hemorrhage

• Source: Ophthalmology Times. Mar2024, Vol. 49 Issue 3, p29-32. 2p.

Record details

CONTINUING MEDICAL EDUCATION. 3 Things You Should Know About Novel Therapies for Retinal Disease.

• Authors : Khanani, Arshad M.^1,2

Subjects: *THERAPEUTIC use of monoclonal antibodies; *DRUG efficacy; *ACCREDITATION

• Source: Ophthalmology Times. Feb2024, Vol. 49 Issue 2, p37-39. 3p.

Record details

From Conjunctivitis to Itch Control: RAD Research to Keep an Eye on.

• Authors : Andrus, Emma; Buchanan, Lauren

Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG efficacy; JANUS kinases

• Source: Dermatology Times. Feb2024, Vol. 45 Issue 2, p24-31. 8p.

Record details

Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience.

• Authors : Chhabra, Nikita; Mead‐Harvey, Carolyn; Dodoo, Christopher A.

Subjects: MIGRAINE prevention; THERAPEUTIC use of monoclonal antibodies; AMERICAN Heart Association

• Source: Headache: The Journal of Head & Face Pain. Mar2024, Vol. 64 Issue 3, p233-242. 10p.

Record details

The introduction of the CGRP monoclonal antibodies and their effect on the prescription patterns of chronic migraine preventive medications in a tertiary headache center: A retrospective, observational analysis.

• Authors : Moskatel, Leon S.; Graber‐Naidich, Anna; He, Zihuai

Subjects: PREVENTION of chronic diseases; MIGRAINE prevention; THERAPEUTIC use of monoclonal antibodies

• Source: Headache: The Journal of Head & Face Pain. Feb2024, Vol. 64 Issue 2, p188-194. 7p.

Record details

Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE‐1 and EVOLVE‐2.

• Authors : MacGregor, E. Anne; Okonkwo, Rose; Detke, Holland C.

Subjects: MIGRAINE prevention; THERAPEUTIC use of monoclonal antibodies; STATISTICSUNITED Kingdom

• Source: Headache: The Journal of Head & Face Pain. Feb2024, Vol. 64 Issue 2, p179-187. 9p.

Record details